Table 3.

Characteristics of patients included in the immunofluorescence study

Variables	Controls (n = 6)	AD (n = 9)	P-value
Age at death (years)
Median [IQR]	70.0 [68.0–73.0]	81.0 [72.0–85.0]	NS
Range	58.0–82.0	69.0–88.0
Female gender, n (%)	2 (33.3)	5 (50.0)	NS
Post mosterm interval
Median [IQR]	10.0 [5.5–23.0]	24.5 [16.0–29.0]	NS
Range	5.0–24.0	8.0–44.0
“A” Thal - n of patients (%)			< 0.001
3 (4 and 5)	0 (0)	8 (88.9)
2 (3)	0 (0)	1 (11.1)
1 (1 and 2)	4 (66.7)	0 (0)
0 (None)	2 (33.3)	0 (0)
“B” Braak Stage - n of patients (%)			< 0.001
3 (V and VI)	0 (0)	9 (100)
2 (III and IV)	1 (16.7)	0 (0)
1 (I and II)	3 (50)	0 (0)
0 (None)	2 (33.3)	0 (0)